Centerline Biomedical receives FDA 510(k) clearance for new IOPS® Viewpoint Catheter, further addressing market need to reduce physician exposure to harmful x-ray radiation during image-guided, endovascular procedures

Centerline Biomedical receives FDA 510(k) clearance for new IOPS® Viewpoint Catheter, further addressing market need to reduce physician exposure to harmful x-ray radiation during image-guided, endovascular procedures

Cleveland, October 4, 2022 – Centerline Biomedical, Inc. (“Centerline”), which recently commercialized its Intra-Operative Positioning Systems IOPS®, has appointed Gulam Khan, Chief Executive Officer.  Mr. Khan has more than two decades of executive...
Centerline Biomedical joins ORSIF

Centerline Biomedical joins ORSIF

Cleveland, October 4, 2022 – Centerline Biomedical, Inc. (“Centerline”), which recently commercialized its Intra-Operative Positioning Systems IOPS®, has appointed Gulam Khan, Chief Executive Officer.  Mr. Khan has more than two decades of executive...
Full Market Release of IOPS V1.4 Software

Full Market Release of IOPS V1.4 Software

Introducing the Full Market Release of the Centerline Biomedical IOPS V1.4 Software IOPS V1.4 Focused on usability enhancements with significant updates in these areas: Improved isolation Performance Enhancements Torus, Sphere, and Line Annotations placed in any...